Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 41
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Pharm Biol ; 51(5): 621-8, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23373711

RESUMEN

CONTEXT: Sulforaphane (SFN) [1-isothiocyanato-4-(methylsulfinyl)butane] is a naturally occurring isothiocyanate found in cruciferous vegetables such as broccoli [Brassica oleracea L. var. italica Plenck. (Brassicaceae)]. Since it is among the most potent bioactive components with antioxidant and antitumor properties, it has received intense attention in the recent years for its chemopreventive properties. OBJECTIVE: The present work determined the rehabilitating role in alleviating the oxidative damage caused by benzo(a)pyrene [B(a)P] to biomolecules and the apoptotic cascade mediated by orally administered isothiocyanate-SFN (9 µmol/mouse/day) against B(a)P (100 mg/kg body weight, i.p.) induced pulmonary carcinogenesis in Swiss albino mice. MATERIALS AND METHODS: Oxidative damage was assessed by measuring lipid peroxidation, 8-hydroxydeoxyguanosine, hydrogen peroxide (H2O2) production, glycoprotein components, protein carbonyl levels and DNA-protein crosslinks. DNA fragmentation by agarose gel electrophoresis and caspase-3 activity by ELISA proved apoptotic induction by SFN along with the protein expression of Bcl-2, Bax and Cyt c. RESULTS: SFN treatment was found to decrease the H2O2 production (p < 0.001) in cancer induced animals, proving its antioxidant potential. Apoptosis was induced by increasing the release of Cyt c (p < 0.001) from mitochondria, decreasing and increasing the expression of Bcl-2 (p < 0.01) and Bax (p < 0.001), respectively. Caspase-3 activity was also enhanced (p < 0.001) which leads to DNA fragmentation in SFN treated groups. CONCLUSION: Our results reflect the rehabilitating role of SFN in B(a)P induced lung carcinogenesis.


Asunto(s)
Apoptosis/efectos de los fármacos , Brassica/química , Neoplasias Pulmonares/tratamiento farmacológico , Tiocianatos/farmacología , Administración Oral , Animales , Anticarcinógenos/administración & dosificación , Anticarcinógenos/aislamiento & purificación , Anticarcinógenos/farmacología , Benzo(a)pireno/toxicidad , Caspasa 3/metabolismo , Fragmentación del ADN/efectos de los fármacos , Electroforesis en Gel de Agar , Ensayo de Inmunoadsorción Enzimática , Femenino , Peróxido de Hidrógeno/metabolismo , Isotiocianatos , Peroxidación de Lípido/efectos de los fármacos , Neoplasias Pulmonares/patología , Ratones , Neoplasias Experimentales/tratamiento farmacológico , Neoplasias Experimentales/patología , Estrés Oxidativo/efectos de los fármacos , Sulfóxidos , Tiocianatos/administración & dosificación , Tiocianatos/aislamiento & purificación
2.
Biochem Biophys Res Commun ; 411(4): 661-6, 2011 Aug 12.
Artículo en Inglés | MEDLINE | ID: mdl-21782799

RESUMEN

The present study has evaluated the chemopreventive effects of gossypol on N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced gastric carcinogenesis and on human gastric adenocarcinoma (AGS) cell line. Gossypol, C(30)H(30)O(8), is a polyphenolic compound that has anti proliferative effect and induces apoptosis in various cancer cells. The aim of this work was to delineate in vivo and in vitro anti-initiating mechanisms of orally administered gossypol in target (stomach) tissues and in human gastric adenocarcinoma (AGS) cell line. In vitro results prove that gossypol has potent cytotoxic effect and inhibit the proliferation of adenocarcinoma (AGS) cell line. In vivo results prove gossypol to be successful in prolonging the survival of MNNG induced cancer bearing animals and in delaying the onset of tumor in animals administrated with gossypol and MNNG simultaneously. Examination of the target (stomach) tissues in sacrificed experimental animals shows that administration of gossypol significantly reduces the level of tumor marker enzyme (carcino embryonic antigen) and pepsin. The level of Nucleic acid contents (DNA and RNA) significantly reduces, and the membrane damage of glycoprotein subsides, in the target tissues of cancer bearing animals, with the administration of gossypol. These data suggest that gossypol may create a beneficial effect in patients with gastric cancer.


Asunto(s)
Adenocarcinoma/tratamiento farmacológico , Antineoplásicos/uso terapéutico , Gosipol/uso terapéutico , Neoplasias Gástricas/tratamiento farmacológico , Adenocarcinoma/patología , Animales , Antineoplásicos/farmacología , Línea Celular Tumoral , Proliferación Celular , Supervivencia Celular , Gosipol/farmacología , Humanos , Masculino , Neoplasias Experimentales/inducido químicamente , Neoplasias Experimentales/tratamiento farmacológico , Neoplasias Experimentales/patología , Pepsina A/análisis , Ratas , Ratas Wistar , Neoplasias Gástricas/patología , Azul de Tripano/química
3.
Asian Pac J Cancer Prev ; 12(1): 103-10, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21517240

RESUMEN

Sulforaphane (SFN) is a natural, biologically active compound extracted from cruciferous vegetables such as broccoli and cabbage with anti-inflammatory and anti-cancer properties. The present study was carried to assess cytoprotective potential in alleviating oxidative stress, to influence the initiation and subsequent carcinogenesis caused by benzo(a)pyrene [B(a)P] administration in the pre- and post-initiation phases of carcinogenesis in Swiss albino mice. Sulforaphane, supplemented orally at a dose of 9µmoles /mouse/day was found to greatly lessen the damaging effects of B(a)P in mice by increasing the availability of reducing equivalents to fulfil the futile GSH redox cycle and replenish GSH biosynthesis, stabilizing the thiol status. Activity of superoxide dismutase and catalase in native gel prove their differential activities in cancer induced and treated animals. SFN was also found to prevent formation of leaky membranes by boosting the antioxidant status leading to maintenance of ATPase activity in B(a)P treated animals. Histopathological analysis confirmed reduction of carcinogen-associated morphological changes in the lung tissue. The results suggest that SFN has potential as a chemopreventive phytochemical against B(a)P induced lung damage in the processes of carcinogenesis.


Asunto(s)
Anticarcinógenos/farmacología , Transformación Celular Neoplásica/efectos de los fármacos , Transformación Celular Neoplásica/metabolismo , Glutatión/metabolismo , Neoplasias Pulmonares/prevención & control , Tiocianatos/farmacología , Adenosina Trifosfatasas/metabolismo , Animales , Antioxidantes/metabolismo , Benzo(a)pireno , Peso Corporal/efectos de los fármacos , Catalasa/metabolismo , Eritrocitos/efectos de los fármacos , Eritrocitos/metabolismo , Femenino , Isotiocianatos , Hígado/efectos de los fármacos , Hígado/metabolismo , Pulmón/efectos de los fármacos , Pulmón/metabolismo , Pulmón/patología , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/patología , Ratones , Tamaño de los Órganos/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Sulfóxidos , Superóxido Dismutasa/metabolismo
4.
Pulm Pharmacol Ther ; 24(1): 110-7, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20833254

RESUMEN

Recent focus of cancer chemoprevention is on intermediate biomarkers capable of detecting early changes that can be correlated with inhibition of carcinogenic initiation and progression. The present study aimed to delineate in vivo anti-initiating mechanisms of orally administered sulforaphane (SFN) with special reference to mitochondrial dysfunction in target (lungs) and non-target (liver) tissues employing benzo(a)pyrene [B(a)P] as the model carcinogen. The recent revival of interest in the study of mitochondria has been stimulated by the evidence that genetic and/or metabolic alterations in this organelle lead to a variety of human diseases including cancer. These alterations could be either causative or contributing factors. Hence the activities of mitochondrial specific enzymes of TCA cycle and the electron transport complexes were analyzed in the experimental groups to assess the ATP production. Short-term tests such as the assessment of antioxidant status and reactive oxygen species (ROS)-induced lipid peroxidation, are widely used in the detection and evaluation of anticarcinogens. The assessment of mitochondrial lipid peroxidation along with the antioxidant status proved worthy for the correlation to the degree of damage. The induction of cancer was confirmed by the immunohistochemistry for Bcl-2. The results prove sulforaphane to be very successful in combating the oxidative stress mediated mitochondrial dysfunction in experimental lung carcinogenesis induced by benzo(a)pyrene.


Asunto(s)
Anticarcinógenos/farmacología , Benzo(a)pireno/toxicidad , Mitocondrias/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Tiocianatos/farmacología , Animales , Femenino , Isocitrato Deshidrogenasa/metabolismo , Isotiocianatos , Malato Deshidrogenasa/metabolismo , Ratones , Mitocondrias/fisiología , Succinato Deshidrogenasa/metabolismo , Sulfóxidos , Superóxido Dismutasa/metabolismo
5.
Biomed Pharmacother ; 65(1): 9-16, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21177068

RESUMEN

Biomarkers are central to the molecular epidemiology approach. Since scientific research progress within this standard, a more complete biological understanding of the specific events underlying the multistage carcinogenesis model is essential. Hence the present investigation was designed to assess the anti-initiating potential of Sulforaphane (SFN) against benzo(a)pyrene [B(a)P] induced lung carcinogenesis in female Swiss Albino Mice by evaluating the activities of xenobiotic markers, and the balance between phase I and phase II carcinogen/drug metabolizing enzymes. We sought to institute whether orally administered SFN reaches the lung tissue and increases functional capacity of detoxification enzymes in this tissue and compare the biochemical changes associated with the initiation of cancer. We demonstrated the inhibitory effects of orally administered sulforaphane on B[a]P-induced aryl hydrocarbon receptor (AHR) activation which subsequently resulted in decreased Phase-I enzyme activities in vivo. The study also highlights that treatment with sulforaphane enhanced the Nuclear factor erythroid 2-related factor 2 (Nrf2) transcription which reflects its nuclear accumulation and DNA binding in mice, together with the induction of phase II enzymes as evident from our results. These modulations by sulforaphane further result in decreased carcinogen-induced stress. By and large, the results suggest an anti-initiating role of sulforaphane in pre- and post-initiation phase of experimentally induced lung carcinogenesis in female Swiss albino mice.


Asunto(s)
Anticarcinógenos/farmacología , Benzo(a)pireno/metabolismo , Neoplasias Pulmonares/prevención & control , Tiocianatos/farmacología , Animales , Benzo(a)pireno/toxicidad , Biotransformación/efectos de los fármacos , Femenino , Glutatión Transferasa/metabolismo , Inactivación Metabólica , Isotiocianatos , Neoplasias Pulmonares/inducido químicamente , Ratones , Factor 2 Relacionado con NF-E2/genética , Receptores de Hidrocarburo de Aril/fisiología , Sulfóxidos
6.
Cell Biol Int ; 33(2): 127-34, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18996213

RESUMEN

The in vitro anti-cancer effect of Cassia auriculata leaf extract (CALE) was evaluated in human breast adenocarcinoma MCF-7 and human larynx carcinoma Hep-2 cell lines. CALE preferentially inhibited the growth of both the cell lines in a dose-dependent manner with IC(50) values of 400 and 500 microg for MCF-7 and Hep-2 cells, respectively. The results showed the anti-cancer action is due to nuclear fragmentation and condensation, associated with the appearance of A(0) peak in cell cycle analysis that is indicative of apoptosis. In addition, CALE treated MCF-7 and Hep-2 cells had decreased expression of anti-apoptotic Bcl-2 protein and increased expression of pro-apoptotic Bax protein, eventually leading a decrease in the Bcl-2/Bax ratio. These results demonstrated that CALE inhibits the proliferation of MCF-7 and Hep-2 cells through induction of apoptosis, making CALE a candidate as new anti-cancer drug.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Apoptosis , Cassia/química , Ciclo Celular/efectos de los fármacos , Extractos Vegetales/farmacología , Neoplasias de la Mama/metabolismo , Línea Celular Tumoral , Humanos , Concentración 50 Inhibidora , Neoplasias Laríngeas/metabolismo , Hojas de la Planta/química , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Proteína X Asociada a bcl-2/metabolismo
7.
Nat Prod Res ; 22(12): 1094-106, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18780251

RESUMEN

Lung cancer is one of the leading causes of cancer death in the world and is notoriously difficult to treat effectively. In the present study, male Swiss albino mice were divided into five groups of six animals each: group I animals received corn oil orally and served as a control; group II cancer-induced animals received benzo(a)pyrene (B[a]P) (50 mg kg(-1) bodyweight dissolved in corn oil, orally) twice weekly for four successive weeks; group III cancer-bearing animals (after 12 weeks of induction) were treated with cisplatin (6 mg kg(-1) bodyweight, i.p.) once weekly for 4 weeks; group IV cancer-bearing animals were treated with cisplatin along with Solanum trilobatum (300 mg kg(-1) bodyweight) orally once weekly for 4 weeks; and group V animals constituted the drug control treated with cisplatin along with S. trilobatum. The serum, lung and liver were investigated biochemically for aryl hydrocarbon hydroxylase, gamma-glutamyl transpeptidase, 5'-nucleotidase, lactate dehydrogenase (LDH) and protein-bound carbohydrate components (hexose, hexosamine and sialic acid). These enzyme activities were increased significantly in cancer-bearing animals compared with control animals. The elevation of these in cancer-bearing animals was indicative of the persistent deteriorating effect of B[a]P in cancer-bearing animals. Our data suggest that cisplatin, administered with S. trilobatum, may extend its chemotherapeutic effect through modulating protein-bound carbohydrate levels and marker enzymes, as they are indicators of cancer. The combination of cisplatin with S. trilobatum could effectively treat the B[a]P-induced lung cancer in mice by offering protection from reactive oxygen species damage and also by suppressing cell proliferation.


Asunto(s)
Antineoplásicos/uso terapéutico , Benzo(a)pireno/toxicidad , Cisplatino/uso terapéutico , Neoplasias Pulmonares/tratamiento farmacológico , Extractos Vegetales/uso terapéutico , Solanum/química , Animales , Antineoplásicos/administración & dosificación , Cisplatino/administración & dosificación , Neoplasias Pulmonares/inducido químicamente , Masculino , Ratones , Extractos Vegetales/administración & dosificación
8.
Nat Prod Res ; 22(8): 672-80, 2008 May 20.
Artículo en Inglés | MEDLINE | ID: mdl-18569708

RESUMEN

The present study is an effort to identify a potent chemopreventive agent against cancer, in which oxidative stress plays an important causative role. The modulatory effect of mangiferin on mitochondrial lipid peroxidation (LPO), tricarboxylic acid (TCA) cycle key enzymes and electron transport chain complexes was investigated against lung carcinogenesis induced by benzo(a)pyrene (50 mg kg(-1) b/w orally) in Swiss albino mice. Decreased activities of electron transport chain complexes and TCA cycle key enzymes such as isocitrate dehydrogenase (ICDH), succinate dehydrogenase (SDH), malate dehydrogenase (MDH) and alpha-ketoglutarate dehydrogenase (alpha-KGDH), in lung cancer bearing animals were observed. Pre- and post-treatment with mangiferin (100 mg kg(-1) b/w orally) for 18 weeks, prevented the above biochemical changes, which were inclined towards normal control animal values. This study further confirms the chemopreventive and chemotherapeutic effect of mangiferin and these results are consistent with our hypothesis that mangiferin is a promising chemopreventive agent.


Asunto(s)
Metabolismo Energético/efectos de los fármacos , Neoplasias Pulmonares/tratamiento farmacológico , Mangifera , Fitoterapia , Xantonas/uso terapéutico , Animales , Benzo(a)pireno , Ciclo del Ácido Cítrico/efectos de los fármacos , Transporte de Electrón/efectos de los fármacos , Peroxidación de Lípido/efectos de los fármacos , Neoplasias Pulmonares/inducido químicamente , Masculino , Ratones , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Xantonas/farmacología
9.
Mol Cell Biochem ; 310(1-2): 129-39, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18157506

RESUMEN

An element/compound that acts as an antioxidant as well as, can increase the oxidative stress offers a new approach in differentiation therapy. Experiments were carried out to determine the effect of selenite on DNA damage and glutathione peroxidase (GPx) activity in N-nitrosodiethylamine (DEN) induced, phenobarbital promoted rat hepatoma. Supra-nutritional level of selenite (4 ppm) was supplemented at either, before-initiation/after-initiation and/or during entire period of the study. At the end of experiment period (20 weeks), extent of DNA damage (alkaline comet assay), selenium concentration, and GPx activity were assessed on nodular tissue (NL) cells, surrounding liver (SL) cells, and whole liver tissue (control) cells. Hepatic selenium level and GPx activity were decreased in DEN and PB-administered animals, whereas the DNA damage was found to be increased in both NL and SL cells compared with control group. However, the DNA damage is more in SL cells than in NL cells. Pre-supplementation of selenite did not show any difference in DNA (strand breaks) damage, selenium, and GPx activity. Increased hepatic selenium concentration and GPx activity were observed in both NL and SL cells in post-supplementation and entire period of selenite supplemented animals compared to DEN + PB treated animals. However, DNA damage was increased in NL but decreased in SL cells. Supplementation of selenite alone for 16 or 20 weeks had shown increased DNA damage, selenium concentration, and GPx activity compared to normal control animals. In summary, cancer bearing animals increased DNA damage and decreased Se level and GPx activity in NL and SL cells and other organs in cancer bearing animals, supplementation of Se further provoked DNA damage (no change in pretreatment) in NL cells, however it decreased DNA damage SL cells and other organs (kidney, lungs, and spleen). On the other hand Se levels and GPx activity were increased in NL and SL cells and other organs of Se-supplemented rats (no difference in group 3 animals). These results demonstrate that, in addition to chemopreventive and chemotherapeutic role of selenite, it also prevents cellular DNA damage induced in cancerous condition.


Asunto(s)
Carcinoma Hepatocelular/enzimología , Roturas del ADN de Doble Cadena/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Neoplasias Hepáticas/enzimología , Selenito de Sodio/farmacología , Alanina Transaminasa/metabolismo , Animales , Peso Corporal/efectos de los fármacos , Carcinoma Hepatocelular/inducido químicamente , Carcinoma Hepatocelular/fisiopatología , Ensayo Cometa , Dietilnitrosamina , Ingestión de Líquidos/efectos de los fármacos , Conducta Alimentaria/efectos de los fármacos , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/fisiopatología , Pruebas de Función Hepática , Neoplasias Hepáticas/inducido químicamente , Neoplasias Hepáticas/fisiopatología , Masculino , Tamaño de los Órganos/efectos de los fármacos , Fenobarbital , Ratas , Ratas Wistar , Selenio/metabolismo , Albúmina Sérica/metabolismo
10.
Toxicol In Vitro ; 21(5): 887-91, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17391909

RESUMEN

Consumption of soy products has been linked to lower the incidence of number of cancers. Genistein, one of the principal soy isoflavones, has been shown to inhibit the growth of a number of tumor cell lines in vitro. In this study, we investigate the effects of genistein on cell growth and apoptosis in human hepatocellular carcinoma HepG2 cell by looking for the formation of nuclear apoptotic bodies and DNA ladder formation. Additionally, flow cytometry analysis with propidium iodide staining has been conducted to detect the apoptotic cells. We found inhibition of cell growth and apoptotic nuclei, DNA fragmentation and increased apoptotic cells after treatment with genistein, indicating apoptotic cell deaths. From these results we observed that genistein inhibits the growth of HepG2 cells and induce apoptosis, however, further definitive studies are needed. These results may support the potentially effective chemopreventive and/or chemotherapeutic of genistein against liver cancer.


Asunto(s)
Anticarcinógenos/farmacología , Antineoplásicos Fitogénicos/farmacología , Apoptosis/efectos de los fármacos , Genisteína/farmacología , División Celular/efectos de los fármacos , Línea Celular Tumoral , Núcleo Celular/efectos de los fármacos , ADN de Neoplasias/efectos de los fármacos , ADN de Neoplasias/ultraestructura , Electroforesis en Gel de Agar , Citometría de Flujo , Humanos , Microscopía Fluorescente
11.
Mol Cell Biochem ; 297(1-2): 73-80, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17006617

RESUMEN

Hepatocellular carcinoma (HCC) is the leading cause of cancer related deaths in the world, with increasing incidence in many developed countries. Epidemiological data suggest that consumption of soy products may be associated with a decreased risk of cancer. We investigate the effects of genistein on cell proliferation, apoptosis and caspase-3 in DEN induced (200 mg/kg body weight; by single intraperitoneal injection) and Phenobarbital promoted (0.05% through drinking water for 14 successive weeks) cancer-bearing rats. Immunohistochemistry was employed to detect cell proliferating markers proliferating cell nuclear antigen (PCNA), DNA fragmentation was determined by agarose gel electrophoresis and terminal deoxynucleatide transferase dUTP nick labeling (TUNEL) staining and caspase by enzyme-linked immunosorbent assay. We found inhibition of cell proliferation, induction of apoptosis and activation of caspase-3 in genistein treated animals. From these results, we conclude that genistein inhibit cell proliferation, induced apoptosis. This activation of caspsase-3 in genistein treated liver cancer bearing animals correlated well with its apoptosis inducing effect.


Asunto(s)
Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Genisteína/farmacología , Neoplasias Hepáticas Experimentales/patología , Animales , Caspasa 3/metabolismo , Proliferación Celular/efectos de los fármacos , Fragmentación del ADN/efectos de los fármacos , Electroforesis en Gel de Agar , Etiquetado Corte-Fin in Situ , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/patología , Neoplasias Hepáticas Experimentales/enzimología , Masculino , Antígeno Nuclear de Célula en Proliferación/metabolismo , Ratas , Ratas Wistar
12.
Pulm Pharmacol Ther ; 19(2): 107-11, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-15975841

RESUMEN

In recent years, considerable emphasis has been focused on identifying new cancer chemopreventive agents, which could be useful for the human population. Piperine is a pure, pungent alkaloid constituent of black and long peppers (Piper nigrum and Piper longum), that acts as an antioxidant and anticancer agent by its numerous macromolecules associated with them. In the present study, piperine was found to suppress benzo(a)pyrene (B(a)p) induced lung cancer in Swiss albino mice. In lung cancer bearing mice, altered levels of total protein and protein bound carbohydrate components (hexose, hexosamine and sialic acid) were observed in serum, lung and liver tissues. Dietary supplementation of piperine (50 mg/kg body weight) to B(a)p administered animals decreased the total protein and protein bound carbohydrate levels of lung cancer bearing animals in during initiation and post-initiation phases. Our data suggest that piperine may extend its chemopreventive effect through modulating the protein bound carbohydrate levels, as they are one of the indicators of tumorigenesis.


Asunto(s)
Alcaloides/farmacología , Antineoplásicos/farmacología , Antioxidantes/farmacología , Benzo(a)pireno , Glicoproteínas/metabolismo , Neoplasias Pulmonares/prevención & control , Piperidinas/farmacología , Animales , Benzodioxoles , Glicoproteínas/sangre , Hígado/metabolismo , Pulmón/metabolismo , Neoplasias Pulmonares/inducido químicamente , Neoplasias Pulmonares/mortalidad , Masculino , Ratones , Alcamidas Poliinsaturadas
13.
Life Sci ; 78(9): 1010-4, 2006 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-16143346

RESUMEN

The modulatory effect of Withania somnifera along with paclitaxel on tricarboxylic acid (TCA) cycle key enzymes and electron transport chain complexes were investigated against lung cancer induced by benzo(a)pyrene in Swiss albino mice. Decreased activities of TCA cycle key enzymes such as isocitrate dehydrogenase (ICDH), succinate dehydrogenase (SDH), malate dehydrogenase (MDH) and alpha-ketoglutarate dehydrogenase (alpha-KGDH) in lung cancer bearing animals were observed. Upon W. somnifera along with paclitaxel administration the above biochemical changes were inclined towards normal control animal values. Activities of mitochondrial enzymes and electron transport complexes were analyzed in the experimental groups to determine the efficiency of energy production. This study further confirms the chemotherapeutic effect of W. somnifera along with paclitaxel which is found to be more effective in the treatment of lung cancer. Thus these results are consistent with our hypothesis that the combination chemotherapy of W. somnifera along with paclitaxel as a promising chemotherapeutic agent.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Ciclo del Ácido Cítrico/efectos de los fármacos , Transporte de Electrón/efectos de los fármacos , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/metabolismo , Paclitaxel/farmacología , Withania/química , Animales , Benzo(a)pireno , Carcinógenos , Neoplasias Pulmonares/inducido químicamente , Masculino , Ratones , Mitocondrias/efectos de los fármacos , Mitocondrias/enzimología , Extractos Vegetales/química , Extractos Vegetales/farmacología
14.
J Ethnopharmacol ; 104(3): 407-9, 2006 Apr 06.
Artículo en Inglés | MEDLINE | ID: mdl-16257158

RESUMEN

The chemopreventive and cytotoxic effect of ethanol extract of Bauhinia variegata (EBV) was evaluated in N-nitrosodiethylamine (DEN, 200 mg/kg) induced experimental liver tumor in rats and human cancer cell lines. Oral administration of ethanol extract of Bauhinia variegata (250 mg/kg) effectively suppressed liver tumor induced by DEN as revealed by decrease in DEN induced elevated levels of serum glutamate pyruvate transaminase (SGPT), serum glutamate oxaloacetate transaminase (SGOT), alkaline phosphatase (ALP), total bilirubin, gamma glutamate transpeptidase (GGTP), lipid peroxidase (LPO), glutathione peroxidase (GPx) and glutathione S-transferase (GST). The extract produced an increase in enzymatic antioxidant (superoxide dismutase and catalase) levels and total proteins when compared to those in liver tumor bearing rats. The histopathological changes of liver samples were compared with respective controls. EBV was found to be cytotoxic against human epithelial larynx cancer (HEp2) and human breast cancer (HBL-100) cells. These results show a significant chemopreventive and cytotoxic effect of ethanol extract of Bauhinia variegata against DEN induced liver tumor and human cancer cell lines.


Asunto(s)
Anticarcinógenos/farmacología , Antineoplásicos/farmacología , Bauhinia , Neoplasias Hepáticas Experimentales/prevención & control , Animales , Línea Celular Tumoral , Dietilnitrosamina , Humanos , Neoplasias Hepáticas Experimentales/inducido químicamente , Masculino , Fitoterapia , Extractos Vegetales/farmacología , Ratas , Ratas Wistar
15.
Mol Cell Biochem ; 280(1-2): 165-72, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16311919

RESUMEN

In the present study, we have evaluated the effects of dietary selenite (Se) on polyamine levels and its influence on N-nitrosodiethylamine (DEN) initiated and Phenobarbital (PB) promoted in rat liver carcinogenesis. Dietary selenite at a concentration of 4 ppm (through drinking water) was administered in rats either before initiation (4 weeks), or during promotion (16 weeks) and entire experimental period (20 weeks). Male Wistar strain of albino rats was treated with single intra peritoneal dose of DEN (200 mg kg(-1) body weight), after 2 weeks the carcinogenic effect was promoted by PB (0.05%; through diet). Alpha fetoprotein (AFP) was investigated after the 20th-week of experimental period. Selenite-treated animals markedly reduced the AFP during the time of pre-selenite [before initiation (4 weeks)] and entire experimental period (20 weeks), administration rather than the promotion period. This infers that anticancer property of selenite depends on the stage of carcinogenesis, rather than duration of treatment. Evaluation of polyamine levels in hepatoma and surrounding liver tissue showed significant difference in the selenite-treated groups compared with pair-fed control groups. Furthermore, histopathological examination showing remarkable difference between control and treated groups. These results demonstrate that selenite can modulate the development of DEN-induced and PB-promoted rat liver carcinogenesis through a polyamine-dependent mechanism.


Asunto(s)
Dietilnitrosamina/farmacología , Neoplasias Hepáticas Experimentales/inducido químicamente , Neoplasias Hepáticas Experimentales/tratamiento farmacológico , Hígado/efectos de los fármacos , Hígado/patología , Fenobarbital/farmacología , Poliaminas/metabolismo , Selenito de Sodio/farmacología , Animales , Peso Corporal/efectos de los fármacos , Hígado/citología , Masculino , Tamaño de los Órganos/efectos de los fármacos , Ratas , Ratas Wistar , Selenito de Sodio/uso terapéutico , alfa-Fetoproteínas/metabolismo
16.
Fitoterapia ; 76(3-4): 296-300, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15890459

RESUMEN

A significant suppression (33.9-66.5%) in the micronuclei formation induced by benzo(a)pyrene and cyclophosphamide was reduced following oral administration of piperine at doses of 25, 50 and 75 mg/kg in mice.


Asunto(s)
Alcaloides/farmacología , Antimutagênicos/farmacología , Micronúcleos con Defecto Cromosómico/efectos de los fármacos , Piperidinas/farmacología , Animales , Benzo(a)pireno/antagonistas & inhibidores , Benzodioxoles , Ciclofosfamida/antagonistas & inhibidores , Relación Dosis-Respuesta a Droga , Masculino , Ratones , Alcamidas Poliinsaturadas
17.
Mol Cell Biochem ; 271(1-2): 101-6, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15881660

RESUMEN

Piperine is a major component of black (Piper nigrum Linn) and long pepper (Piper longum Linn) used widely in various systems of traditional medicine. We have evaluated the effect of piperine on mitochondrial tricarboxylic acid cycle and phase I and glutathione-metabolizing enzymes in Benzo(a)pyrene induced experimental lung carcinogenesis in swiss albino mice. Lung cancer bearing mice showed a significant decrease in the activities of mitochondrial enzymes-isocitrate dehydrogenase (ICDH), -ketoglutarate dehydrogenase (KDH), succinate dehydrogenase (SDH), malate dehydrogenase (MDH) and significantly increased NADPH-Cytochorome reductase (NADPH-C reductase), cytochrome P450 (cyt-p450) and cytochrome b5(cyt-b5). The activities of glutathione-metabolizing enzymes glutathione peroxidase(GPx), glutathione reductase (GR) and glucose-6-phospho dehydrogenase(G6PDH) were significantly lowered in lung-cancer bearing mice when compared with control mice. Piperine supplementation to tumour-induced animals significantly lowered the phase-I enzymes (NADPH-C reductase, cyt-p450 and cyt-b5)) and there was a rise in glutathione-metabolizing enzymes (GPx, GR and G6PDH), which indicated an antitumour and anti-cancer effect. Comparison of normal control mice and mice administered piperine only as drug control showed no significant variations in enzyme activities. Piprine administration to benzo(a)pyrene induced animals significantly increased the activities of mitochondrial enzymes, thereby suggesting its role in mitochondrial energy production.


Asunto(s)
Alcaloides/farmacología , Anticarcinógenos/farmacología , Enzimas/metabolismo , Glutatión/metabolismo , Neoplasias Pulmonares/prevención & control , Mitocondrias/metabolismo , Piperidinas/farmacología , Animales , Benzo(a)pireno/toxicidad , Benzodioxoles , Ciclo del Ácido Cítrico/efectos de los fármacos , Inhibidores Enzimáticos del Citocromo P-450 , Enzimas/efectos de los fármacos , Hígado/efectos de los fármacos , Hígado/enzimología , Neoplasias Pulmonares/inducido químicamente , Masculino , Ratones , Mitocondrias/efectos de los fármacos , Alcamidas Poliinsaturadas
18.
Cell Biochem Funct ; 22(4): 265-71, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15248187

RESUMEN

The anticarcinogenic/antioxidant potential of sodium selenite (Se), a micronutrient, was evaluated on liver tumourigenesis induced by N-nitrosodiethylamine (DEN) and promoted by phenobarbital (PB; 0.05% in diet). Male, albino rats of the Wistar strain were exposed intravenously to a single dose of DEN (200 mg x kg(-1) body weight). Se (4 ppm in drinking water) was supplemented before initiation, or during initiation and/or during the promotion period of carcinogenesis. At the end of 16 weeks (after DEN administration) nodular incidence, the total number of nodules and non-enzymic antioxidants such as vitamin E, vitamin C, total thiol, protein thiol and non-protein thiol contents were measured in hepatoma, surrounding tissue and kidney tissue of control and experimental groups. In hepatoma-bearing animals the above biochemical changes were decreased when compared with normal control animals. On Se treatment throughout the study, (20 weeks) the above biochemical changes reverted to normal levels. Pre- and post-treatment with Se also shows a tendency to reverse the above changes. The results indicate that prior application of Se significantly reverses the adverse changes produced during the tumourigenesis. Furthermore, prior applications of Se significantly reduced the cumulative number of tumours per tumour-bearing animals. The present study reveals the antitumour potential of Se against DEN-induced liver carcinogenesis.


Asunto(s)
Anticarcinógenos/uso terapéutico , Antioxidantes/uso terapéutico , Neoplasias Hepáticas Experimentales/prevención & control , Selenito de Sodio/uso terapéutico , Animales , Ácido Ascórbico/análisis , Enfermedad Hepática Inducida por Sustancias y Drogas , Cocarcinogénesis , Dietilnitrosamina/toxicidad , Evaluación Preclínica de Medicamentos , Hiperplasia , Hígado/química , Hígado/efectos de los fármacos , Hepatopatías/prevención & control , Neoplasias Hepáticas Experimentales/inducido químicamente , Masculino , Fenobarbital/toxicidad , Lesiones Precancerosas/inducido químicamente , Lesiones Precancerosas/prevención & control , Ratas , Ratas Wistar , Compuestos de Sulfhidrilo/análisis , Vitamina E/análisis
19.
Biomed Pharmacother ; 58(4): 264-7, 2004 May.
Artículo en Inglés | MEDLINE | ID: mdl-15183854

RESUMEN

The current study was designed to evaluate the effects of oral supplementation of the piperine on lung tumour initiation by orally applied benzo(a)pyrene (B(a)p). To evaluate the effects of orally supplemented piperine on lung tumour initiation by B(a)p, its effects on ATPase enzymes were first evaluated. Lung cancer bearing mice showed an increase in erythrocyte membrane and tissues ATPase enzymes (Na(+)/K(+)-ATPases, Mg(2+)-ATPases and Ca(2+)-ATPases). Na(+) K-ATPase and Mg-ATPase enzyme activities were decreased and calcium ATPase increased (P < 0.05) in erythrocyte membrane and tissues of lung cancer bearing animals compared with control groups. The elevation of these enzyme activities in membrane and tissues were indicative of the persistent deteriorating effect of B(a)p in cancer bearing animals. These enzyme activities were reversed to near normal control values in animals treated with piperine (50 mg/kg body weight). It is apparent that the beneficial effect of piperine is primarily exerted on the during initiation phase and post-initiation stage of B(a)p induced lung carcinogenesis. Overall, these data indicative that piperine has chemopreventive effects when administered orally on lung cancer bearing animals.


Asunto(s)
Alcaloides/uso terapéutico , Anticarcinógenos/uso terapéutico , Inhibidores Enzimáticos/uso terapéutico , Membrana Eritrocítica/efectos de los fármacos , Peroxidación de Lípido/efectos de los fármacos , Neoplasias Pulmonares/tratamiento farmacológico , Piperidinas/uso terapéutico , Animales , Benzo(a)pireno , Benzodioxoles , ATPasa de Ca(2+) y Mg(2+)/metabolismo , ATPasas Transportadoras de Calcio/metabolismo , Carcinógenos , Membrana Eritrocítica/enzimología , Neoplasias Pulmonares/inducido químicamente , Neoplasias Pulmonares/enzimología , Masculino , Ratones , Alcamidas Poliinsaturadas , ATPasa Intercambiadora de Sodio-Potasio/metabolismo
20.
Phytomedicine ; 11(4): 309-14, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15185843

RESUMEN

Apigenin, a dietary plant derived flavone subclass of flavonoid is expected to play a role in cancer chemoprevention and cancer chemotherapy. Here we designed our experiment to establish whether treatment of apigenin (25 mg/kg body weight) for 14 consecutive days to (N-nitrosodiethylamine) DEN induced (200 mg/kg body weight; by single ip. injection) and phenobarbital promoted (0.05% through drinking water for 14 successive weeks) rats provide protection against the oxidative stress caused by the carcinogen. The level of lipid peroxidation (LPO) markedly increased in carcinogen administered animals, which was brought back to near normal by apigenin treatment. In contrast the activities/levels of the antioxidant status both in liver and kidney were decreased in carcinogen administered animals, which was recouped back to near normal upon apigenin administration. From our findings we concluded that apigenin prevents LPO and protects antioxidant system in DEN induced and phenobarbital promoted hepatocellular carcinogenesis.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Antioxidantes/farmacología , Flavonoides/farmacología , Riñón/efectos de los fármacos , Peroxidación de Lípido/efectos de los fármacos , Hígado/efectos de los fármacos , Fitoterapia , Plantas Medicinales , Animales , Antineoplásicos Fitogénicos/administración & dosificación , Antineoplásicos Fitogénicos/uso terapéutico , Antioxidantes/administración & dosificación , Antioxidantes/uso terapéutico , Apigenina , Dietilnitrosamina , Flavonoides/administración & dosificación , Flavonoides/uso terapéutico , Riñón/enzimología , Riñón/metabolismo , Hígado/enzimología , Hígado/metabolismo , Neoplasias Hepáticas/inducido químicamente , Neoplasias Hepáticas/prevención & control , Masculino , Fenobarbital , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...